Leukemia-2022-768x461-EN-V2
UFCW Canada lifetime fundraising for Leukemia & Lymphoma Society of Canada tops $49 million thanks to $1.86 million campaign in 2021-2022
17 juin 2022 13h22 HE | UFCW Canada
TORONTO, June 17, 2022 (GLOBE NEWSWIRE) --  Another year of pandemic restrictions presented unique challenges for UFCW Canada’s fundraising efforts on behalf of the Leukemia & Lymphoma Society...
22157.jpg
$4.31 Billion Worldwide Hematology Analyzers and Reagents Industry to 2030 - Identify Growth Segments for Investment
30 déc. 2021 05h33 HE | Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Hematology Analyzers and Reagents Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
ufcw.png
$2.1 million campaign pushes UFCW Canada lifetime fundraising for The Leukemia & Lymphoma Society of Canada past $47.2 million TORONTO, July 26, 2021 (GLOBE NEWSWIRE) -- Despite an extraordinarily challenging year, UFCW Canada members and Local Unions were undeterred in their extraordinary ongoing fundraising efforts,...
ARM_logo full.jpg
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan
03 févr. 2021 09h00 HE | The Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan ATMPs are uniquely positioned to attack cancer at its source, bringing life-changing benefits to patients BRUSSELS, BELGIUM –...
MEDIA ADVISORY: Majo
MEDIA ADVISORY: Major donation from UFCW Canada to be presented June 13 to Leukemia and Lymphoma Society of Canada to accelerate advancements in blood cancer treatments
12 juin 2018 16h32 HE | UFCW Canada
TORONTO, June 12, 2018 (GLOBE NEWSWIRE) -- On Wednesday, June 13, 2018, UFCW Canada (United Food and Commercial Workers union) will be presenting its annual fundraising donation to the Leukemia and...
Kura Oncology Logo
Kura Oncology Announces Presentation of Preliminary Clinical Data for Tipifarnib in HRAS Mutant Squamous Cell Carcinomas of the Head and Neck at TAT 2017
27 févr. 2017 07h30 HE | Kura Oncology, Inc.
LA JOLLA, Calif., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical stage biopharmaceutical company, today announced an oral presentation for its lead product...
Kura Oncology to Present at the Jefferies 2015 Global Healthcare Conference
27 mai 2015 07h30 HE | Kura Oncology, Inc.
LA JOLLA, Calif., May 27, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and...